Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001625101-22-000021
Filing Date
2022-04-01
Accepted
2022-04-01 16:28:03
Documents
4
Period of Report
2022-05-19

Document Format Files

Seq Description Document Type Size
1 DEF 14A plse-20220519xdef14a.htm DEF 14A 644695
2 GRAPHIC plse-20220519xdef14ag001.jpg GRAPHIC 1311
3 GRAPHIC plse-20220519xdef14ag002.jpg GRAPHIC 97833
4 GRAPHIC plse-20220519xdef14ag003.jpg GRAPHIC 102519
  Complete submission text file 0001625101-22-000021.txt   923889
Mailing Address 3957 POINT EDEN WAY HAYWARD CA 94545
Business Address 3957 POINT EDEN WAY HAYWARD CA 94545 510-906-4600
Pulse Biosciences, Inc. (Filer) CIK: 0001625101 (see all company filings)

EIN.: 465696597 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37744 | Film No.: 22798664
SIC: 3841 Surgical & Medical Instruments & Apparatus